1. Home
  2. NUTX vs PMN Comparison

NUTX vs PMN Comparison

Compare NUTX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$168.10

Market Cap

729.5M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$8.27

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
PMN
Founded
2011
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
729.5M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NUTX
PMN
Price
$168.10
$8.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$252.50
$72.67
AVG Volume (30 Days)
181.0K
33.1K
Earning Date
11-19-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
17.98
N/A
Revenue
$981,195,633.00
N/A
Revenue This Year
$104.36
N/A
Revenue Next Year
$4.10
N/A
P/E Ratio
$9.35
N/A
Revenue Growth
236.03
N/A
52 Week Low
$28.82
$6.27
52 Week High
$193.00
$39.75

Technical Indicators

Market Signals
Indicator
NUTX
PMN
Relative Strength Index (RSI) 56.25 70.99
Support Level $156.15 $8.00
Resistance Level $180.76 $9.15
Average True Range (ATR) 14.18 0.58
MACD -1.32 -0.26
Stochastic Oscillator 37.73 44.44

Price Performance

Historical Comparison
NUTX
PMN

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: